Scott Terrillion, Sec'y, Chief Compliance & G.C at Cara Therapeutics, Inc. (CARA), sold 2,481 shares at $4.91 ($12K) on 2023-04-04, disclosed to the SEC on 2023-04-06.
Scheduled sale ($12k) by Sec'y, Chief Compliance & G.C under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CARA | SELL | 2024-03-04 | $3K | — | Filing → |
| CARA | SELL | 2024-02-12 | $4K | — | Filing → |
| CARA | SELL | 2023-06-27 | $9K | — | Filing → |